| Year | Total Annual Revenue (EUR million) | Gross Profit / Gross Operating Profit (EBITDA) (EUR million) | Operating Profit / EBIT (EUR million) | Net Income (EUR million) |
| 2025 | 2,395.700 | 511.600 | 196.600 | 91.300 |
| 2024 | 2,409.200 | 561.100 | 256.800 | 145.400 |
| 2023 | 2,260.100 | 526.800 | 259.200 | 155.100 |
| 2022 | 2,119.100 | 518.700 | 278.700 | 178.500 |
| 2021 | 1,948.100 | 468.300 | 246.000 | 157.800 |
| 2020 | 1,555.500 | 371.000 | 168.500 | 101.000 |
| 2019 | 1,732.100 | 370.600 | 177.100 | 108.700 |
| 2018 | 1,362.234 | 225.467 | 153.310 | 100.443 |
| 2017 | 1,265.994 | 212.491 | 149.677 | 100.578 |
| 2016 | 1,133.100 | 186.900 | 127.000 | 63.600 |
Amplifon S.p.A. in brief
Amplifon S.p.A. is a listed company in the Medical Instruments industry, based in Italy. It was founded in 1950. Its last known market value was $7.7 B (January 2024); there is no current figure. In the year to December 2025 it had sales of $2.7 B and a net profit of $103 M, about 4 cents of profit for every dollar of sales. It employs about 11,265 people. Its shares trade under the symbol AMP.MI (Borsa Italiana).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Amplifon S.p.A.
Amplifon SpA is an Italian company based in Milan and the world's largest hearing aid retailer.
From Wikipedia: read the full article · text available under CC BY-SA 4.0
Amplifon S.p.A. timeline
- 1950
- 🏁
- 2012
- •Legal Entity Identifier issuedLEI ZYXJDNVM2JI3VBM8G556 registered.
- 2022
- 📊Market cap passed $10 billion$11.1 billion on 7 January 2022, from $9.3 billion on 1 January 2021.
Events of Amplifon S.p.A. from Wikidata, the GLEIF LEI register and our market-cap rankings. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in Italy: #24 (Jan 2020) · #21 (Jan 2021) · #16 (Jan 2022) · #24 (Dec 2022) · #20 (Jul 2023) · #23 (Jan 2024)
Key ratios
- P/E ratio
- —
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- 3.8%
- Operating margin
- 8.2%
- Return on equity
- 8.8%
- Liabilities / assets
- 74.4%
- Revenue growth
- +3.6%
- Revenue per employee
- $240 K
- Profit per employee
- $9 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $2.7B | +3.6% | $222M | $103M | 3.8% |
| Dec 2024 | $2.6B | — | $278M | $157M | 6.0% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $468M | $64M | $404M | $0.45 | — |
| Dec 2024 | $488M | $92M | $396M | $0.69 | — |
Annual results
- Revenue
- $2.7 B
- Operating income
- $222 M
- Net income
- $103 M
For year ending December-2025 · source: official annual report (ESEF)
Balance sheet
- Total assets
- $4.6 B
- Total liabilities
- $3.4 B
- Total equity
- $1.2 B
As of December-2025
AMPLIFON SPA - Yearly Revenue and Net Income - in Million EUR
AMPLIFON SPA - BALANCE SHEET SUMMARY- in Million EUR
| Year | Total Assets (EUR mm) | Total Liabilities (EUR mm) | Total Equity (EUR mm) |
| 2025 | 3,892.916 | 2,894.391 | 998.525 |
| 2024 | 3,992.762 | 2,842.538 | 1,150.224 |
| 2023 | 3,693.215 | 2,591.537 | 1,101.678 |
| 2022 | 3,575.465 | 2,535.115 | 1,040.350 |
| 2021 | 3,515.291 | 2,588.010 | 927.281 |
| 2020 | 3,228.472 | 2,426.604 | 801.868 |
| 2019 | 2,851.338 | 2,155.223 | 696.115 |
| 2018 | 2,255.570 | 1,659.623 | 595.947 |
| 2017 | 1,465.419 | 877.001 | 588.418 |
| 2016 | 1,405.963 | 848.303 | 557.660 |
Brands of Amplifon S.p.A. (2)#
Retail chain · since 1949
Retail chain
Source: Wikidata. Brands whose Wikidata item names Amplifon S.p.A. (or a subsidiary of it) as owner, maker or parent organization; each brand's page links to its item
Mutual funds holding Amplifon S.p.A.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Goldman Sachs International Small Cap Insights FundGoldman Sachs Asset Management, L.P. | 3.47 M | $49 M | — | 0.68% | +34% | Jul 31, 2026 |
| 🇺🇸 T. Rowe Price International Discovery FundT. Rowe Price Associates, Inc. | 2.46 M | $35 M | — | 0.52% | −2.6% | Jul 31, 2026 |
| 🇺🇸 Oakmark International Small Cap FundHarris Associates L.P. | 2.73 M | $30 M | — | 2.5% | −3.6% | Jun 30, 2026 |
| 🇺🇸 Vanguard Total International Stock Index FundThe Vanguard Group, Inc. | 2.08 M | $29 M | — | <0.01% | +16% | Jul 31, 2026 |
| 🇺🇸 SMALLCAP World Fund IncSMALLCAP World Fund Inc | 1.90 M | $21 M | — | 0.02% | new | Jun 30, 2026 |
| 🇺🇸 Global X Artificial Intelligence & Technology ETFGlobal X Management Company LLC | 1.58 M | $20 M | — | 0.18% | +4.1% | May 31, 2026 |
| 🇺🇸 Vanguard Developed Markets Index FundThe Vanguard Group, Inc. | 1.38 M | $15 M | — | <0.01% | +19% | Jun 30, 2026 |
| 🇺🇸 iShares Core MSCI EAFE ETFBlackRock Fund Advisors | 1.05 M | $15 M | — | <0.01% | +18% | Jul 31, 2026 |
| 🇺🇸 AQR Long-Short Equity FundAQR CAPITAL MANAGEMENT, LLC | 1.35 M | $15 M | — | 0.19% | −45% | Jun 30, 2026 |
| 🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC | 1.06 M | $11 M | — | <0.01% | +1.0% | Jun 30, 2026 |
| 🇺🇸 iShares MSCI EAFE Small-Cap ETFBlackRock Fund Advisors | 545,692 | $8 M | — | 0.06% | +11% | Jul 31, 2026 |
| 🇺🇸 Vanguard Ftse All-World Ex-Us Small-Cap Index FundThe Vanguard Group, Inc. | 543,047 | $8 M | — | 0.06% | +20% | Jul 31, 2026 |
| 🇺🇸 Nuveen Quant International Small Cap Equity FundTeachers Advisors, LLC | 490,987 | $7 M | — | 0.48% | +1.7% | Jul 31, 2026 |
| 🇺🇸 Bridge Builder International Equity FundOLIVE STREET INVESTMENT ADVISERS LLC | 548,217 | $6 M | — | 0.02% | +1.2% | Jun 30, 2026 |
| 🇺🇸 Harbor International FundHarbor Capital Advisors, Inc. | 410,285 | $6 M | — | 0.15% | −2.7% | Jul 31, 2026 |
| 🇺🇸 AQR Equity Market Neutral FundAQR CAPITAL MANAGEMENT, LLC | 518,989 | $6 M | — | 0.20% | −35% | Jun 30, 2026 |
| 🇺🇸 Vanguard European Stock Index FundThe Vanguard Group, Inc. | 337,934 | $5 M | — | 0.01% | +17% | Jul 31, 2026 |
| 🇺🇸 BlackRock Advantage International FundBlackRock Advisors, LLC | 336,449 | $4 M | — | 0.05% | +39% | May 29, 2026 |
| 🇺🇸 International Core Equity 2 PortfolioDimensional Fund Advisors LP | 285,153 | $4 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Schwab International Small-Cap Equity ETFCharles Schwab Investment Management, Inc. | 297,067 | $4 M | — | 0.07% | new | May 31, 2026 |
| 🇺🇸 iShares Core MSCI Total International Stock ETFBlackRock Fund Advisors | 178,835 | $3 M | — | <0.01% | +1.3% | Jul 31, 2026 |
| 🇺🇸 iShares Core MSCI International Developed Markets ETFBlackRock Fund Advisors | 166,021 | $2 M | — | <0.01% | +4.6% | Jul 31, 2026 |
| 🇺🇸 Vanguard Total World Stock Index FundThe Vanguard Group, Inc. | 115,553 | $2 M | — | <0.01% | +30% | Jul 31, 2026 |
| 🇺🇸 Fidelity Total International Index FundFidelity Management & Research Company LLC | 86,786 | $1 M | — | <0.01% | +16% | Jul 31, 2026 |
| 🇺🇸 Schwab Fundamental International Small Equity ETFCharles Schwab Investment Management, Inc. | 95,529 | $1 M | — | 0.04% | +20% | May 31, 2026 |
| 🇺🇸 State Street SPDR Portfolio Developed World ex-US ETFSSGA Funds Management, Inc. | 95,484 | $1 M | — | <0.01% | −0.1% | Jun 30, 2026 |
| 🇺🇸 iShares Core MSCI Europe ETFBlackRock Fund Advisors | 72,748 | $1 M | — | 0.01% | +9.7% | Jul 31, 2026 |
| 🇺🇸 Harbor Diversified International All Cap FundHarbor Capital Advisors, Inc. | 52,031 | $1 M | — | 0.09% | −8.0% | Jul 31, 2026 |
| 🇺🇸 International Tilts Master PortfolioBlackRock Advisors, LLC | 63,377 | $1 M | — | 0.07% | −13% | Jun 30, 2026 |
| 🇸🇪 Handelsbanken Global Småbolag Index CriteriaHandelsbanken Fonder AB | 60,829 | $1 M | — | 0.02% | +9.8% | Jun 30, 2026 |
| 🇺🇸 Fidelity SAI International Small Cap Index FundFidelity Management & Research Company LLC | 44,660 | $1 M | — | 0.06% | +26% | Jul 31, 2026 |
| 🇺🇸 International Equity FundGuideStone Capital Management, LLC | 57,429 | $1 M | — | 0.05% | −53% | Jun 30, 2026 |
| 🇺🇸 SMALLCAP World FundCapital Research and Management Company | 51,829 | $1 M | — | 0.02% | new | Jun 30, 2026 |
| 🇺🇸 Schwab Fundamental International Small Equity Index FundCharles Schwab Investment Management, Inc. | 30,130 | $0 M | — | 0.06% | +32% | Jul 31, 2026 |
| 🇺🇸 State Street Global All Cap Equity ex-U.S. Index PortfolioSSGA Funds Management, Inc. | 37,364 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Avantis International Equity ETFAmerican Century ETF Trust | 30,203 | $0 M | — | <0.01% | +154% | May 31, 2026 |
| 🇸🇪 Storebrand EuropaStorebrand Asset Management AS | 32,955 | $0 M | — | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 International Vector Equity PortfolioDimensional Fund Advisors LP | 25,120 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP | 24,895 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Esg International Stock ETFThe Vanguard Group, Inc. | 26,708 | $0 M | — | <0.01% | +14% | May 31, 2026 |
| 🇺🇸 SA Morgan Stanley International Equities PortfolioSunAmerica Asset Management, LLC | 21,685 | $0 M | — | 0.09% | new | Jul 31, 2026 |
| 🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 21,326 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 AVIP BlackRock Advantage International Equity PortfolioCONSTELLATION INVESTMENTS INC | 26,553 | $0 M | — | 0.08% | +59% | Jun 30, 2026 |
| 🇺🇸 AQR MS Fusion HV FundAQR CAPITAL MANAGEMENT, LLC | 23,371 | $0 M | — | 0.36% | +21% | Jun 30, 2026 |
| 🇺🇸 iShares MSCI Europe Small-Cap ETFBlackRock Fund Advisors | 17,114 | $0 M | — | 0.13% | +18% | Jul 31, 2026 |
| 🇺🇸 Invesco RAFI Developed Markets ex-U.S. Small-Mid ETFInvesco Capital Management LLC | 14,505 | $0 M | — | 0.06% | +17% | Jul 31, 2026 |
| 🇺🇸 T. Rowe Price Global Allocation FundT. Rowe Price Associates, Inc. | 9,784 | $0 M | — | 0.02% | −2.8% | Jul 31, 2026 |
| 🇺🇸 Dimensional VA International Small PortfolioDimensional Fund Advisors LP | 9,628 | $0 M | — | 0.03% | no change | Jul 31, 2026 |
| 🇺🇸 International Social Core Equity PortfolioDimensional Fund Advisors LP | 8,586 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 BlackRock Multi-Asset Income PortfolioBlackRock Advisors, LLC | 8,516 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 International Sustainability Core 1 PortfolioDimensional Fund Advisors LP | 7,609 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 iShares MSCI World Small-Cap ETFBlackRock Fund Advisors | 7,043 | $0 M | — | 0.01% | −25% | May 31, 2026 |
| 🇺🇸 LVIP Dimensional International Core Equity FundLincoln Financial Investments Corporation | 7,094 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Global Atlantic BlackRock Disciplined International Core PortfolioGlobal Atlantic Investment Advisors, LLC | 5,748 | $0 M | — | 0.04% | no change | Jun 30, 2026 |
| 🇺🇸 State Street SPDR Portfolio Europe ETFSSGA Funds Management, Inc. | 5,593 | $0 M | — | <0.01% | −2.3% | Jun 30, 2026 |
| 🇺🇸 Brighthouse/Dimensional International Small Company PortfolioBrighthouse Investment Advisers, LLC | 4,705 | $0 M | — | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Avantis International Small Cap Equity ETFAmerican Century ETF Trust | 3,793 | $0 M | — | 0.02% | +18% | May 31, 2026 |
| 🇺🇸 International Small Company TrustJohn Hancock Variable Trust Advisers LLC | 3,025 | $0 M | — | 0.03% | no change | Jun 30, 2026 |
| 🇺🇸 AZL DFA International Core Equity FundAllianz Investment Management LLC | 2,889 | $0 M | — | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 FlexShares Morningstar Developed Markets ex-US Factor Tilt Index FundNorthern Trust Investments, Inc. | 2,112 | $0 M | — | <0.01% | −70% | Jul 31, 2026 |
| 🇺🇸 BlackRock Dynamic High Income PortfolioBlackRock Advisors, LLC | 1,631 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Avantis Responsible International Equity ETFAmerican Century ETF Trust | 1,210 | $0 M | — | <0.01% | +0.9% | May 31, 2026 |
| 🇺🇸 Avantis International Equity FundAmerican Century ETF Trust | 1,006 | $0 M | — | <0.01% | no change | May 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 63 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Ownership and subsidiaries
- Amplifon Belgium🇧🇪 Dilbeek
Amplifon S.p.A. scorecard#
Passes 3 of the 5 checks that could be worked out. Fiscal year 2025.
Valuationnot known
- –P/E below its peers' medianNo market cap.
- –Price to book below its peers' medianNo market cap.
- –Price to sales below its peers' medianNo market cap.
- –Free cash flow yield above 5%No market cap.
- –Earnings yield above the 10-year Treasury yieldNo market cap.
- –The price assumes slower growth than the last three years'No market cap.
Growth1 of 2
- ✓Revenue grew in the newest year3.6%Revenue up 3.6% in fiscal 2025.
- –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- ✗Earnings per share grew in the newest year0.45 vs 0.69Diluted EPS 0.45 in fiscal 2025 against 0.69 the year before (report's currency).
- –Net income higher than five years earlierNet income of five years earlier is not on file.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability2 of 3
- ✓Profitable in the newest year$103 MNet income $103 M in fiscal 2025.
- –Profitable in each of the last five yearsFive years of net income are not on file.
- ✓Operating margin above its peers' median8.2%8.2% against Medical Instruments's median of 7.2% (46 companies).
- ✗Return on equity above 15%8.7%8.7% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial healthnot known
- –Short-term assets cover short-term liabilitiesCurrent assets and liabilities are not on file.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- –Cash from operations positive in each of the last three yearsThree years of operating cash flow are not on file.
- –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returnsnot known
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- –Share count up no more than 2% in a yearShare counts of two years are not on file.
- –Dividends and buybacks above 3% of the market valueNo market cap.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (esef), the medians of Medical Instruments, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from Amplifon S.p.A.'s statements, beside the median of Medical Instruments.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | 8.2% | 7.2% | |
| Net margin | 3.8% | 3.8% | |
| Return on equity | 8.7% | 3.5% | |
| Revenue growth | 3.6% | 8.9% | |
| Free cash flow margin | 15.0% | 6.3% |
3of 5on the Piotroski tests of financial strength
Amplifon S.p.A.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in EUR millions; per-share figures in EUR; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 2,396−0.6%100% | 2,409+6.6%100% | 2,260+6.7%100% | 2,119+8.8%100% | 1,948—100% | |
| Total costs and expenses | 1,882+1.5%78.5% | 1,855+6.4%77.0% | 1,742+8.2%77.1% | 1,610+8.5%76.0% | 1,485—76.2% | |
| Operating income | 197−23.5%8.2% | 257−0.9%10.7% | 259−7.0%11.5% | 279+13.3%13.2% | 246—12.6% | |
| Income before tax | 132−33.0%5.5% | 197−6.2%8.2% | 210−13.9%9.3% | 244+9.1%11.5% | 223—11.5% | |
| Income tax | 40−21.4%1.7% | 51−6.4%2.1% | 55−15.8%2.4% | 65+8.7%3.1% | 60—3.1% | |
| Income from continuing operations | — | — | 155−13.3%6.9% | 179+9.3%8.4% | 164—8.4% | |
| Income from discontinued operations | — | — | — | 0—0.0% | −5.8—−0.3% | |
| Net income including minority interests | 92−37.1%3.8% | 146−6.1%6.0% | 155−13.3%6.9% | 179+13.3%8.4% | 158—8.1% | |
| Minority interests' share of net income | 0.2+10.7%0.0% | 0.2—0.0% | −0.1−145%−0.0% | 0.3+340%0.0% | 0.1—0.0% | |
| Net income attributable to shareholders | 91−37.2%3.8% | 145−6.3%6.0% | 155−13.1%6.9% | 179+13.1%8.4% | 158—8.1% | |
| Earnings per share, basic | 0.41−36.2%— | 0.64−7.1%— | 0.69−12.9%— | 0.80+13.4%— | 0.70—— | |
| Earnings per share, diluted | 0.40−37.2%— | 0.64−6.7%— | 0.69−12.6%— | 0.79+13.4%— | 0.69—— | |
| Balance sheet | ||||||
| Cash and cash equivalents | 309+6.9%7.9% | 289+49.5%7.2% | 193+7.5%5.2% | 180−33.1%5.0% | 269—7.6% | |
| Receivables | 222−2.2%5.7% | 227−1.9%5.7% | 231+20.4%6.3% | 192+13.9%5.4% | 169—4.8% | |
| Inventory | 82−11.5%2.1% | 93+5.5%2.3% | 88+15.8%2.4% | 76+21.9%2.1% | 63—1.8% | |
| Current assets | 763+5.2%19.6% | 725+16.7%18.2% | 621+4.8%16.8% | 593−8.3%16.6% | 647—18.4% | |
| Property, plant and equipment | 237−6.6%6.1% | 254+14.6%6.4% | 222+14.5%6.0% | 193+3.5%5.4% | 187—5.3% | |
| Right-of-use (leased) assets | 462−6.1%11.9% | 492+2.9%12.3% | 478+5.8%12.9% | 452+3.3%12.6% | 437—12.4% | |
| Goodwill | 1,927−0.9%49.5% | 1,945+8.1%48.7% | 1,800+2.6%48.7% | 1,754+4.3%49.1% | 1,681—47.8% | |
| Other intangible assets | 381−11.1%9.8% | 428+2.8%10.7% | 417−0.8%11.3% | 420+1.3%11.7% | 415—11.8% | |
| Investments in associates | 0.0−99.2%0.0% | 2.5+3.4%0.1% | 2.4+16.8%0.1% | 2.1−1.9%0.1% | 2.1—0.1% | |
| Non-current assets | 3,130−4.2%80.4% | 3,268+6.4%81.8% | 3,072+3.0%83.2% | 2,983+4.0%83.4% | 2,869—81.6% | |
| Total assets | 3,893−2.5%100% | 3,993+8.1%100% | 3,693+3.3%100% | 3,575+1.7%100% | 3,515—100% | |
| Current liabilities | 1,256+7.4%32.3% | 1,170−0.8%29.3% | 1,179+11.6%31.9% | 1,056+19.2%29.5% | 886—25.2% | |
| Lease liabilities (non-current) | 364−6.0%9.4% | 388+1.0%9.7% | 384+4.1%10.4% | 369+4.4%10.3% | 353—10.0% | |
| Non-current liabilities | 1,638−2.0%42.1% | 1,672+18.4%41.9% | 1,412−4.5%38.2% | 1,479−13.1%41.4% | 1,702—48.4% | |
| Shareholders' equity | 998−13.2%25.6% | 1,150+4.5%28.8% | 1,101+6.0%29.8% | 1,039+12.2%29.0% | 925—26.3% | |
| Minority interests | 0.3+40.1%0.0% | 0.2−70.8%0.0% | 0.8−58.8%0.0% | 1.8−12.5%0.1% | 2.1—0.1% | |
| Total equity | 999−13.2%25.6% | 1,150+4.4%28.8% | 1,102+5.9%29.8% | 1,040+12.2%29.1% | 927—26.4% | |
| Total liabilities and equity | 3,893−2.5%100% | 3,993+8.1%100% | 3,693+3.3%100% | 3,575+1.7%100% | 3,515—100% | |
| Cash-flow statement | ||||||
| Cash from operating activities | 415−8.1%17.3% | 451+9.1%18.7% | 414−9.8%18.3% | 459−0.8%21.6% | 462—23.7% | |
| Capital expenditure | −56—−2.4% | −85—−3.5% | −75—−3.3% | −57—−2.7% | −52—−2.7% | |
| Intangible assets bought | −62—−2.6% | −61—−2.6% | −66—−2.9% | −59—−2.8% | −62—−3.2% | |
| Acquisitions, net of cash acquired | −62—−2.6% | −193—−8.0% | −108—−4.8% | −85—−4.0% | −420—−21.5% | |
| Cash from investing activities | −187—−7.8% | −335—−13.9% | −261—−11.6% | −194—−9.1% | −534—−27.4% | |
| Debt issued | 109−44.9%4.6% | 199—8.2% | −0.0—−0.0% | −128−1727%−6.1% | 7.9—0.4% | |
| Debt repaid | −0.0—−0.0% | −0.8—−0.0% | −50—−2.2% | −0.1—−0.0% | −41—−2.1% | |
| Shares bought back | −108—−4.5% | −25—−1.1% | 0—0.0% | −53—−2.5% | −31—−1.6% | |
| Dividends paid | −65—−2.7% | −66—−2.7% | −65—−2.9% | −58—−2.7% | −49—−2.5% | |
| Cash from financing activities | −202—−8.4% | −19—−0.8% | −135—−6.0% | −354—−16.7% | −209—−10.7% | |
| Exchange-rate effect on cash | −5.2—−0.2% | −1.5—−0.1% | −3.5−5263%−0.2% | 0.1−98.0%0.0% | 3.4—0.2% | |
| Report | ESEF | ESEF | ESEF | ESEF | ESEF | |
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: ESEF annual reports (filings.xbrl.org) · as of Dec 31, 2025. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
Where Amplifon S.p.A. operates: 2 countries#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 1 subsidiaries on file.
| Country | Presence | Revenue there |
|---|---|---|
| 🇮🇹 Italy | Headquarters2 offices | — |
| 🇧🇪 Belgium | 1 subsidiary | — |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
Lobbying by Amplifon S.p.A.#
$200 K spent on lobbying the US Congress and federal agencies in 2025, most often on budget/appropriations, health issues and medicare/medicaid.
- Budget/Appropriations4 reports
- Health Issues4 reports
- Medicare/Medicaid4 reports
Lobbying firms hired in 2025
Thorn Run Partners $200 K
| Year | Spending | Own lobbyists | Reports |
|---|---|---|---|
| 2026 (so far) | $150 K | — | 3 |
| 2025 | $200 K | — | 4 |
| 2024 | $200 K | — | 4 |
| 2023 | $200 K | — | 4 |
| 2022 | $280 K | — | 4 |
| 2021 | $270 K | — | 7 |
| 2020 | $210 K | — | 4 |
| 2019 | $240 K | — | 4 |
| 2018 | $230 K | — | 3 |
Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “Amplifon USA”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero
H-1B hiring at Amplifon S.p.A.#
2 labor condition applications certified in fiscal 2026 for 2 positions, at a median wage of $125 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Senior Business Intelligence SpecialistBusiness Intelligence Analysts | 2 | $125 K |
Where: Melissa, TX 2
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2026 | 2 | 2 | $125 K | 2 |
| FY2025 | 4 | 4 | $95 K | 5 |
| FY2024 | 3 | 3 | $280 K | 3 |
| FY2023 | 2 | 2 | $128 K | 2 |
| FY2022 | 1 | 1 | $135 K | 1 |
| FY2021 | 1 | 1 | $85 K | 1 |
| FY2020 | 2 | 2 | $98 K | 2 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Amplifon (USA), Inc.
How Amplifon S.p.A. compares in Medical Instruments
- Revenue$2.7 B · higher than 81% of 120
- Net margin3.8% · higher than 31% of 114
- Revenue growth3.6% · higher than 25% of 49
Peer comparison · Medical Instruments
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Amplifon S.p.A.🇮🇹 | $7.7 B | — | 3.8% | +3.6% |
| Intuitive Surgical, Inc.🇺🇸 | $155.6 B | 52.6× | 25.5% | +20.5% |
| EssilorLuxottica S.A.🇫🇷 | $88.0 B | 32.1× | 8.1% | +4.5% |
| HOYA Corporation🇯🇵 | $56.2 B | 32.8× | 25.4% | — |
| Becton, Dickinson and Company🇺🇸 | $54.0 B | 57.4× | 4.2% | +8.2% |
| Alcon Inc.🇨🇭 | $37.1 B | 37.9× | 9.4% | +4.9% |
| ResMed Inc.🇺🇸 | $35.3 B | 22.1× | 27.8% | +9.8% |
| West Pharmaceutical Services, Inc.🇺🇸 | $27.1 B | 42.4× | 18.8% | +6.3% |
| Terumo Corporation🇯🇵 | $24.9 B | 27.0× | 12.0% | — |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Intuitive Surgical, Inc.$155.6 B
- EssilorLuxottica S.A.$88.0 B
- HOYA Corporation$56.2 B
- Becton, Dickinson and Company$54.0 B
- Alcon Inc.$37.1 B
- ResMed Inc.$35.3 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As on 2020
- Profile updated:
- Nov 4, 2026
Figures from Official annual report (ESEF), value.today research, Wikipedia, Wikimedia Commons, Wikidata, GLEIF register.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Amplifon S.p.A.? Verify and update this profile — free
Show Amplifon S.p.A.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.